and currently Japan does not prescribe it in their national protocol, which I referenced at the time
Approved antiviral agents in Japan
Remdesivir, which has been granted special approval in Japan, is the only antiviral agent for treating COVID-19 (as of November 2020). It is indicated for patients requiring supplemental oxygen, and patients should be carefully monitored after administration of remdesivir because acute kidney or liver damage may occur. The administrative procedure (completing a web-based survey) specified by the Ministry of Health, Labour and Welfare (18) must be followed to obtain remdesivir.
Other antiviral agents and agents that have not yet been approved in Japan
Although their use for the treatment of COVID-19 has not yet been approved, favipiravir, tocilizumab, ciclesonide, nafamostat, sarilumab, nelfinavir, ivermectin, and convalescent plasma are sometimes considered for off-label use or for use based on the findings of investigator-initiated or industry-sponsored clinical studies.
Another claim is that the Covid-19 coronavirus somehow mutated itself into extinction in Japan.
www.forbes.com
even if you set all that aside, if studies are still pending, then studies are pending....why do you think it should be employed
now?
why hang your hat on this ONE study when plenty of others have concluded that ivermectin is not an effective treatment?
the reality is that there have been enough prior studies that the vast majority of the world have ceased the use of ivermectin
www.nature.com
why you are latched so tightly to this particular topic is beyond comprehension
(edit: expanded and added links)